IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer

T cell-based immunotherapy has significantly improved treatment options for many malignancies. However, despite these and other therapeutic improvements over the last decades, gastrointestinal cancers, in particular pancreatic, hepatic and gastric cancer, are still characterized by high relapse rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutz, Martina S., Zekri, Latifa, Weßling, Laura, Berchtold, Susanne, Heitmann, Jonas S., Lauer, Ulrich M., Jung, Gundram, Salih, Helmut R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140336/
https://www.ncbi.nlm.nih.gov/pubmed/37122707
http://dx.doi.org/10.3389/fimmu.2023.1163136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140336/
https://www.ncbi.nlm.nih.gov/pubmed/37122707
http://dx.doi.org/10.3389/fimmu.2023.1163136

Ejemplares similares